Lipase Assay

SKU:
DZ132A

Diazyme's Lipase Assay provides an extended linear range up to 250 U/L with virtually no interferences from triglyceride 300 mg/dL, hemoglobin 150 mg/dL, and bilirubin up to 20 mg/dL. Diazyme's Lipase Assay has excellent…

$130.00 - $395.00
Adding to cart… The item has been added
Product Details

Diazyme's Lipase Assay provides an extended linear range up to 250 U/L with virtually no interferences from triglyceride 300 mg/dL, hemoglobin 150 mg/dL, and bilirubin up to 20 mg/dL. Diazyme's Lipase Assay has excellent inter-assay and intra-assay precision.

Product Catalog Number Format Method
Kit DZ132A R1/R2 (Dual Vial Liquid Stable) Dual Vial Liquid Stable, Methyl-Resorufin
Calibrator DZ132A-Cal Cal: 1 Level (Lyophilized)  
Control DZ132A-Con Con: 2 Level (Lyophilized)  

Product Features

Diazyme's Lipase Assay provides an extended linear range up to 250 U/L with virtually no interferences from triglyceride 300 mg/dL, hemoglobin 150 mg/dL, and bilirubin up to 20 mg/dL. Diazyme's Lipase Assay has excellent inter-assay and intra-assay precision. The assay has an excellent correlation to an existing 6’ Methylresorufin method with an R² of 0.997, y-intercept of 3.9443 and Slope of 0.50054.

Downloads

Assay Principle

The method for the determination of lipase is based on the cleavage of specific chromogenic lipase substrate 1,2-O-dilaurylrac-glycero-3-glutaric acid-(6'methyl-resorufin)-ester emulsified in stabilized micro-particles. In the presence of specific activators of pancreatic lipase as colipase, calcium ions and bile acids, the substrate is converted to 1,2-O-dilauryl-rac-glycerol and glutaric acid-6'-methylresorufinester which decomposes spontaneously to glutaric acid and methylresorufin. The increase of absorbance at 580 nm, due to methylresorufin formation, is proportional to the activity of lipase in the sample.

Lipase Assay procedure

Intended use

The Diazyme Lipase assay in conjunction with lipase assay calibrator set is intended for the in vitro quantitative determination of lipase in serum or plasma.

Regulatory Status

FDA 510K Exempt CE